advertisement
http://lm360.us/Milfeld-mother-of-Jancik-from-Auer?Fleitesgr=122
.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
5 / 5
.